GENFLOW BIOSCIENCES PLC (WQ5) - Total Liabilities

Latest as of June 2025: €771.38K EUR ≈ $901.83K USD

Based on the latest financial reports, GENFLOW BIOSCIENCES PLC (WQ5) has total liabilities worth €771.38K EUR (≈ $901.83K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore WQ5 net asset momentum to track the company's year-over-year net asset growth rate.

GENFLOW BIOSCIENCES PLC - Total Liabilities Trend (2021–2024)

This chart illustrates how GENFLOW BIOSCIENCES PLC's total liabilities have evolved over time, based on quarterly financial data.

GENFLOW BIOSCIENCES PLC Competitors by Total Liabilities

The table below lists competitors of GENFLOW BIOSCIENCES PLC ranked by their total liabilities.

Company	Country	Total Liabilities
First Media Tbk JK:KBLV	Indonesia	Rp1.44 Trillion
Biocardia Inc NASDAQ:BCDA	USA	$2.78 Million
Tartisan Nickel Corp F:8TA	Germany	€1.32 Million
Xelpmoc Design And Tech Limited NSE:XELPMOC	India	Rs107.98 Million
UDAYSHIVAKUMAR INFRA ORD (BSE) NSE:USK	India	Rs1.64 Billion
Winamp Group SA PA:ALPET	USA	€5.84 Million
Ranix INC KQ:317120	Korea	₩18.68 Billion
authID Inc. NASDAQ:AUID	USA	$1.82 Million

Liability Composition Analysis (2021–2024)

This chart breaks down GENFLOW BIOSCIENCES PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is GENFLOW BIOSCIENCES PLC worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.61	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-2.55	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.65	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how GENFLOW BIOSCIENCES PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for GENFLOW BIOSCIENCES PLC (2021–2024)

The table below shows the annual total liabilities of GENFLOW BIOSCIENCES PLC from 2021 to 2024.

Year	Total Liabilities	Change
2024-12-31	€788.92K ≈ $922.33K	+37.93%
2023-12-31	€571.96K ≈ $668.68K	+127.88%
2022-12-31	€250.99K ≈ $293.43K	+13.35%
2021-12-31	€221.43K ≈ $258.87K	--

About GENFLOW BIOSCIENCES PLC

F:WQ5 Germany Biotechnology

Market Cap

$13.15 Million

€11.25 Million EUR

Market Cap Rank

#26371 Global

#2264 in Germany

Share Price

€0.02

Change (1 day)

-26.32%

52-Week Range

€0.01 - €0.03

All Time High

€0.16